Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Daily Feed
  • Analyst Insights & IR
  • Disclosures
    • Semiconductors
    • Energy
    • Robotics
    • Bio & Healthcare
  • Toggle search form

[Disclosure] Alteogen (196170) to Host Investor Relations (IR) Conference for Major Overseas Institutional Investors

Posted on October 10, 2025July 11, 2026 By K-STOCK Editor No Comments on [Disclosure] Alteogen (196170) to Host Investor Relations (IR) Conference for Major Overseas Institutional Investors

Source Fact: Financial Supervisory Service DART / 2025-10-10

Disclosure Type: Report on Investor Relations (IR) Holding

💡 3-Second Summary

Alteogen will host an Investor Relations conference (NDR) from October 16 to 17 in Hong Kong for major overseas institutional investors to explain its platform technology and pipeline status and conduct a Q&A session.

📊 1. [Key Disclosure Content & Major Figures Summary]

  • Date & Time: October 16, 2025 – October 17, 2025 (09:00 – 18:00 Local Time)
  • Location: Hong Kong
  • Target Audience: Major overseas institutional investors
  • Purpose: To enhance corporate awareness through the introduction of the company and core technology/pipelines
  • Method: NDR (Non-Deal Roadshow)
  • Key Topics: Explanation of platform technology and pipeline status/plans, and Q&A
  • Sponsoring Institution: CLSA
  • IR Material Availability: Scheduled to be posted on the Korea Exchange Korea Investor’s Network for Disclosure website on October 16, 2025

📈 2. [Expert View: What This Disclosure Means for Investors]

This disclosure is an announcement regarding Alteogen hosting an Investor Relations conference for major overseas institutional investors. According to the disclosure, the event will be held in Hong Kong via the NDR (Non-Deal Roadshow) method, covering explanations and Q&A regarding its platform technology and pipeline status/plans.

The purpose is specified as enhancing corporate awareness, and the disclosure does not explain any specific financial impacts or potential changes in financial metrics. Investors may review the related facts through the IR materials scheduled to be available on the Korea Exchange website on October 16. Since any prospective impacts or market outcomes beyond the official text remain uncertain, investors should interpret this disclosure focusing strictly on the confirmed event details and schedules.

📝 Editor’s Comment (by K-STOCK Editor)

This Investor Relations event announced by Alteogen is an NDR schedule taking place in Hong Kong from October 16 to 17, 2025, for major overseas institutional investors. The official purpose stated in the disclosure is enhancing corporate awareness through the introduction of platform technology and pipelines, with CLSA as the sponsoring institution. The official IR materials are scheduled to be posted on the Korea Exchange network on October 16, and tracking should be limited strictly to these verified facts and schedules.

📢 Disclaimer & Source Information

Source: This content has been newly structured and written based on the official data submitted to the Financial Supervisory Service Electronic Disclosure System (DART).

Investment Risk Notice: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest solely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

🐂
BULLS
VS
🐻
BEARS

🔥 Bulls vs Bears, drop your analysis in the comments!

Disclosures, Bio & Healthcare

Post navigation

Previous Post: [Disclosure] SK hynix (000660) Designated as ‘Investment Caution’ Stock Due to Excessive Single-Account Trading
Next Post: [Disclosure] Alteogen (196170) to Host NDR (Non-Deal Roadshow) in Hong Kong for Major Global Institutional Investors

Related Posts

[Disclosure] Alteogen(196170) Approves Delisting from KOSDAQ and Relisting on KOSPI at Extraordinary Shareholders’ Meeting Disclosures
[Disclosure] Alteogen (196170) to Host NDR (Non-Deal Roadshow) in Hong Kong for Major Global Institutional Investors Disclosures
[Disclosure] Alteogen (196170) Scores Huge Win: Eylea Biosimilar ‘Eyzanfy’ Secures Official MFDS Marketing Approval in South Korea Disclosures
[Disclosure] Alteogen(196170) Signs Exclusive License Agreement with GSK Subsidiary for ALT-B4 Valued up to KRW 420.0B Disclosures
[Disclosure] Alteogen (196170) to Receive USD 15M (KRW 21.9B) Milestone Payment from MSD Following European Approval of Keytruda SC Disclosures
[Disclosure] Alteogen(196170) Designated as Short Selling Overheated Stock… Short Selling Banned on Dec 8 Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hana Micron (067310) Lifted from Investment Warning Stock Status; Reclassified to Investment Caution on June 9 with Re-designation WarningJuly 8, 2026
  • [Discount Reversal via ADR Listing and Entry into an HBM-Led Super Cycle: SK hynix 000660]July 7, 2026
  • [Discount Narrowing via ADR Listing Momentum and Capital Allocation Diversification: SK Square 402340]July 7, 2026
  • Gaon Cable (000500): Structural Re-rating Driven by North American Infrastructure Expansion and AI Data Center Demand ShocksJuly 7, 2026
  • Hugel (145020): Passing the Trough with Q2 Earnings Surprise and Accelerated U.S. Direct Sales DeploymentJuly 7, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme